Italian consumption of plasma-derived factor VIII after the SIPPET study

被引：1
|
作者：
Traversa, Giuseppe [1 ]
Trotta, Francesco [2 ]
机构：
[1] Natl Inst Hlth, Natl Ctr Epidemiol, Pharmacoepidemiol Unit, Rome, Italy
[2] Lazio Reg Hlth Serv, Dept Epidemiol, Via Cristoforo Colombo 112, I-00147 Rome, Italy
来源：
BLOOD TRANSFUSION | 2017年 / 15卷 / 03期
关键词：
HEMOPHILIA-A; UPDATE;
D O I：
10.2450/2017.0035-17
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：283 / 284
页数：2
相关论文
共 50 条
  • [21] RELATION OF ACTIVATED FACTOR-VIII TO THE POTENCY IN FACTOR-VIII CONCENTRATES, COMPARISON OF PLASMA-DERIVED AN RECOMBINANT FACTOR-VIII
    MINAMIYAMA, T
    ITO, Y
    OGURI, S
    KOBAYASHI, K
    TAKEDA, M
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 942 - 942
  • [22] RECENT ADVANCES IN THE PREPARATION OF PLASMA-DERIVED AND RECOMBINANT COAGULATION FACTOR-VIII
    BRAY, GL
    JOURNAL OF PEDIATRICS, 1990, 117 (03): : 503 - 507
  • [23] Biochemical and immunochemical investigations of different plasma-derived and recombinant factor VIII products
    Josic, D
    Stadler, M
    Buchacher, A
    Schulz, P
    Schutz, R
    Wiry, G
    Schwinn, H
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2095 - P2095
  • [24] Effect of plasma-derived or recombinant factor VIII on inhibitor development: a systematic review
    Iorio, A.
    Halimeh, S.
    Goldenberg, N.
    Kenet, G.
    Young, G.
    Brandao, L.
    HAEMOPHILIA, 2010, 16 : 74 - 74
  • [25] Immune Tolerance Induction (ITI) with a Plasma-Derived Factor VIII for Patients with Hemophilia a and Inhibitors: A Retrospective Study
    Escobar, Miguel A.
    Shaffer, Linda
    Holguin, Mark
    McCavit, Timothy
    Rajan, Sandeep K.
    Amega, Novinyo
    BLOOD, 2019, 134
  • [26] ADAMTS13 content in plasma-derived factor VIII/von Willebrand factor concentrates
    Peyvandi, Flora
    Mannucci, Pier M.
    Valsecchi, Carla
    Pontiggia, Silvia
    Farina, Claudio
    Retzios, Anastassios D.
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (10) : 895 - 898
  • [27] ADAMTS-13 content of plasma-derived factor VIII/von Willebrand factor concentrates
    Kingsland, Sarah
    Feldman, Peter
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : 667 - 668
  • [28] Proteomic characterization of plasma-derived clotting factor VIII-von Willebrand factor concentrates
    Clifton, James G.
    Huang, Feilei
    Kovac, Spomenka
    Yang, Xinli
    Hixson, Douglas C.
    Josic, Djuro
    ELECTROPHORESIS, 2009, 30 (20) : 3636 - 3646
  • [29] The binding kinetics of B-domain-deleted recombinant factor VIII and plasma-derived factor VIII to phospholipid vesicles
    Brekkan, E
    Wrangel, M
    Sandberg, H
    THROMBOSIS AND HAEMOSTASIS, 1999, : 235 - 235
  • [30] Prospective, observational study of plasma-derived factor VIII/von Willebrand factor in immune tolerance induction: the PRISM registry
    Kruse-Jarres, R.
    Gilsenan, A.
    Spears, J.
    Kaye, J. A.
    HAEMOPHILIA, 2015, 21 (02) : E122 - E124
12345